Can naltrexone cause hypertension?

Can Naltrexone Cause Hypertension?

Yes, naltrexone-bupropion ER can cause slight elevations in blood pressure and heart rate, requiring monitoring, particularly in the first 12 weeks of treatment, and is contraindicated in uncontrolled hypertension. However, naltrexone monotherapy does not appear to cause clinically significant hypertension.

Key Distinction: Combination vs Monotherapy

The cardiovascular effects differ substantially between naltrexone alone and naltrexone-bupropion ER:

Naltrexone-Bupropion ER (Combination)

Blood pressure and heart rate monitoring is mandatory when using naltrexone-bupropion ER 1, 2. The 2025 AACE guidelines explicitly state that "a slight elevation in BP and heart rate have been observed, so it is important to monitor BP and heart rate at the start of therapy and at regular intervals" 2.

• Contraindicated in uncontrolled hypertension 2
• Monitor BP and heart rate especially during the first 12 weeks 1
• The 2016 AACE guidelines specifically recommend that naltrexone-bupropion ER "should be avoided if other weight-loss medications can be used because weight loss assisted by naltrexone ER/bupropion ER cannot be expected to reduce blood pressure" 3

A 2024 meta-analysis confirmed that bupropion (alone or combined with naltrexone) significantly increases both systolic BP (WMD: 1.34 mmHg) and diastolic BP (WMD: 0.93 mmHg), with greater effects at doses >360 mg and treatment duration ≤26 weeks 4. The subgroup analysis showed that changes in systolic BP were more pronounced with the bupropion-naltrexone combination compared to bupropion alone 4.

Naltrexone Monotherapy

The FDA label for naltrexone monotherapy does not list hypertension as an adverse effect 5. The most common adverse reactions include nausea, headache, dizziness, nervousness, fatigue, insomnia, anxiety, and gastrointestinal symptoms—but not hypertension 5.

Research evidence supports this distinction. A 2025 study found that extended-release naltrexone (XR-NTX) was actually associated with significant decreases in diastolic blood pressure in heroin users, with systolic pressure showing a declining trend 6. Animal studies similarly showed that naltrexone did not alter blood pressure in spontaneously hypertensive rats 7.

Clinical Management Algorithm

When prescribing naltrexone-bupropion ER:

1. Screen for contraindications:

   • Uncontrolled hypertension (absolute contraindication) 2
   • Seizure disorders
   • Chronic opioid use
   • Pregnancy/breastfeeding

2. Baseline assessment:

   • Measure BP and heart rate before initiation 2
   • Document cardiovascular history

3. Monitoring schedule:

   • Check BP and heart rate at start of therapy 2
   • Intensive monitoring during first 12 weeks 1
   • Continue periodic monitoring at regular intervals thereafter 2

4. Special considerations:

   • Use caution with beta blockers (naltrexone-bupropion may increase beta blocker levels; start at lower dose and monitor heart rate closely) 2
   • In patients with existing hypertension, other weight-loss medications (orlistat, lorcaserin, phentermine-topiramate ER, liraglutide) are preferred 3

Common Pitfall to Avoid

Do not assume all naltrexone formulations have the same cardiovascular profile. The hypertensive effect is attributable to the bupropion component in the combination product, not naltrexone itself. Naltrexone monotherapy (used for opioid or alcohol dependence at 50 mg daily) does not require the same intensive BP monitoring as the combination product 5.

The cardiovascular safety of naltrexone-bupropion ER remains incompletely characterized, as the planned cardiovascular outcomes trial was terminated due to data compromise 2. This uncertainty reinforces the need for careful patient selection and monitoring.